← Leaderboards
Elisabetta Patorno
Brigham And Women'S Hospital
$4,890,327
Attributed
$4,890,327
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$2,664,421 · 1
NIH$2,225,906 · 2
By mechanism
U01$2,664,421 · 1
R01$1,564,946 · 1
K08$660,960 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Krista F Huybrechts$10,039,261
- Shirley Wang$7,765,582
- Joshua K Lin$16,782,382
- Sebastian G. Schneeweiss$14,258,306
- Brian Thomas Bateman$6,450,805
Others in their field
Other Emerging Leaders on “Cardiovascular System”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Lisa Newman · Research Triangle Institute$22,725,934
- Craig Reist · Research Triangle Institute$22,725,934
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
Research focus
Cardiovascular SystemInfrastructureProductionWomanPharmaceutical PreparationsEventLinkPharmacoepidemiologySafetyAdverse EventEffectivenessResidual StateNovel StrategiesDiabetes MellitusDesignDrug MonitoringBeneficiaryCaringDecision MakingCareer DevelopmentCareerBaseAgingComparative Safety
Grant awards (8)
Novel approaches to improve comparative effectiveness research of medical and surgical weight reduction strategies in clinical practice$772,572
R01 · FY2025 · DK · contact PI
Novel approaches to improve comparative effectiveness research of medical and surgical weight reduction strategies in clinical practice$792,374
R01 · FY2024 · DK · contact PI
Enhancing evidence generation by linking randomized clinical trials (RCTs) to real world data (RWD)$1,397,144
U01 · FY2022 · FD · contact PI
Enhancing evidence generation by linking randomized clinical trials (RCTs) to real world data (RWD)$1,267,277
U01 · FY2021 · FD · contact PI
Novel Approaches to Monitor the Safety and Effectiveness of Newly Marketed Diabetes Medications in Older Adults Considering Frailty and Multimorbidity$165,240
K08 · FY2021 · AG · contact PI
Novel Approaches to Monitor the Safety and Effectiveness of Newly Marketed Diabetes Medications in Older Adults Considering Frailty and Multimorbidity$165,240
K08 · FY2020 · AG · contact PI
Novel Approaches to Monitor the Safety and Effectiveness of Newly Marketed Diabetes Medications in Older Adults Considering Frailty and Multimorbidity$165,240
K08 · FY2019 · AG · contact PI
Novel Approaches to Monitor the Safety and Effectiveness of Newly Marketed Diabetes Medications in Older Adults Considering Frailty and Multimorbidity$165,240
K08 · FY2018 · AG · contact PI